Common questions about Cathejell (FAQ)
Q: Does Cathejell have an expiry date?
A: Yes, regulatory documents confirm that the product is assigned an expiry date. This date is printed on the package and should be noted.
Q: Is Cathejell refrigerated or stored at room temperature?
A: Official instructions require the gel to be stored at a temperature below 25 C (77°F). The product is indicated to be kept protected from light in its original carton.
Q: Is it possible for the gel to cause a local infection?
A: The official product classification describes Cathejell as an Antiseptic Combination Preparation. This means it contains an active ingredient (chlorhexidine) that provides a bactericidal and bacteriostatic effect, which is used to provide antiseptic support during procedures.
Q: Is Cathejell the same as other lubricating gels?
A: No, Cathejell is officially classified as a Local Anesthetic and Antiseptic Combination Preparation. This designation distinguishes it from simpler lubricating gels that contain only a single, non-medicated component.
Q: What is the difference between Cathejell and plain surgical lubricant?
A: According to official descriptions, the main difference is the active ingredients. Cathejell contains Lidocaine Hydrochloride (a local anesthetic) and Chlorhexidine Gluconate (an antiseptic), in addition to the sterile gel base found in plain lubricants.
Q: Can Cathejell be used by women?
A: Regulatory information indicates that the gel is approved for use in procedures involving the urethra for both male and female patients. The product is also used in other applications such as certain gynaecological procedures.
Q: Are there different strengths or types of Cathejell available?
A: Yes, regulatory documents describe different formulations. These include the dual combination containing Lidocaine and Chlorhexidine, as well as formulations that contain a lubricant and antiseptic only.
Q: Can Cathejell be used if a person has certain known allergies?
A: Official labeling states that the gel is officially contraindicated (should not be used) for individuals with a known hypersensitivity or allergy. This includes allergies to the active components (Lidocaine, Chlorhexidine) or any of the other inactive ingredients in the preparation.
Q: What is the official classification of Cathejell (e.g., medical device vs. drug)?
A: The specific formulation containing both lidocaine and chlorhexidine is classified by regulatory bodies as a Medicinal Product, which is an Anesthetic and Antiseptic Combination Preparation. This classification distinguishes it from a simple medical device.
Q: Can Cathejell be used in combination with other topical medicines?
A: Official documentation includes a note of caution when the gel is used on wounded, inflamed, or traumatized skin. Damage to the mucosa (the wet lining) can lead to increased systemic absorption of the active ingredients, which is the primary safety concern.
Q: What are the inactive ingredients in Cathejell?
A: Regulatory product information lists several inactive ingredients. These typically include substances like glycerol, hydroxyethylcellulose, hydrochloric acid, sodium hydroxide, and water for injection.
Q: Why do some people feel a brief stinging sensation when Cathejell is applied?
A: Official safety information lists temporary stinging or irritation at the application site as one of the documented local reactions. This is a potential side effect that may be experienced by some patients.
Q: Does Cathejell have any effect on fertility or pregnancy risk?
A: Official labeling focuses on use during pregnancy, stating that it is generally not recommended. A careful assessment of potential benefit versus risk is advised by a physician during both pregnancy and lactation.
Q: Does Cathejell interact with alcohol or affect driving ability?
A: Regulatory documents note that signs of systemic toxicity, which are sometimes reported when high plasma levels are reached, include effects on the Central Nervous System (CNS) such as lightheadedness, dizziness, and nervousness.
Q: What does Cathejell feel like when it's applied?
A: The official safety profile notes that some patients may experience local reactions. These can include a temporary stinging sensation or a sense of heat at the site of application.
Q: How should Cathejell be handled to keep it sterile?
A: Official instructions emphasize that the single-use syringe is sterile-packed. They provide specific steps for one-handed preparation and application, which are consistent with the product's design for single-use sterility.
Q: Why is Cathejell sometimes called 'lidocaine gel'?
A: The preparation is often referred to by the name of its primary active ingredient, Lidocaine Hydrochloride. This component is the one responsible for providing the topical anesthetic (numbing) effect.
Q: Is it considered safe to use Cathejell if a person has a kidney issue?
A: Official documents state that cautious use and potential dose reduction is required for individuals with existing severe impairment of renal (kidney) or hepatic (liver) function. This is due to the body's reduced ability to process the active ingredients.
Q: Can Cathejell cause an allergic reaction?
A: Official safety documents confirm that allergic reactions and hypersensitivity to the active ingredients or excipients are documented potential adverse effects. These types of severe reactions are reported to be rare.
Q: What is the purpose of the lubricant part of Cathejell?
A: The sterile, viscous gel base is the lubricant component. Its purpose is to assist with the smooth insertion of medical instruments and to enhance patient comfort during necessary procedures.
Q: Is the onset of action different for different procedures?
A: Regulatory information states that the local anesthetic effect generally begins within 3 to 5 minutes after application. The product's regulatory dosage is often varied based on the specific area of application.
Q: Why do some people report feeling dizzy after use?
A: Official safety documents link the symptom of dizziness to the potential for systemic absorption of the Lidocaine component. Dizziness is categorized as an early sign of possible systemic toxicity if the drug enters the bloodstream in higher-than-expected concentrations.
Q: Are there documented cases of overdose with Cathejell?
A: Official safety information discusses the potential for systemic toxicity and severe adverse reactions. This risk arises if high plasma levels of Lidocaine are reached, which can occur from use exceeding the prescribed dose.
Q: Can Cathejell cause irritation if used on broken skin?
A: Official warnings advise caution if the gel is used on damaged or traumatized mucosal tissue. This caution is advised because damaged tissue can increase the rate of systemic absorption of the active ingredients.
Q: Are there alternatives to Cathejell that my doctor might use?
A: Clinical evidence themes acknowledge that comparative studies have examined this gel against other lidocaine-containing gel formulations used for similar procedures. This implies the existence of products in the same therapeutic class.
Q: Does Cathejell contain any preservatives?
A: Certain regulatory documents state that the gel formulation is preservative-free. The product information also confirms that it is free of parabens.
Q: What happens if I accidentally get Cathejell in my eye?
A: Official directions for use state that contact with the eyes should be avoided during the preparation and instillation process.
Q: Why is the research evidence for Cathejell usually focused on specific procedures?
A: The research evidence primarily reflects the drug's approved indications. The studies focus on its authorized uses as a sterile lubricant and surface anesthetic for procedures such as urological and endoscopic interventions.
